{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T10:37:15Z","timestamp":1785926235017,"version":"3.56.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DELTAS Africa Initiative","award":["DEL-15-004"],"award-info":[{"award-number":["DEL-15-004"]}]},{"name":"DELTAS Africa Initiative","award":["DEL-15-004"],"award-info":[{"award-number":["DEL-15-004"]}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["R120442"],"award-info":[{"award-number":["R120442"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["R120442"],"award-info":[{"award-number":["R120442"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR134531"],"award-info":[{"award-number":["NIHR134531"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR134531"],"award-info":[{"award-number":["NIHR134531"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR134531"],"award-info":[{"award-number":["NIHR134531"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR134531"],"award-info":[{"award-number":["NIHR134531"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R010161\/1"],"award-info":[{"award-number":["MR\/R010161\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R02118X\/1"],"award-info":[{"award-number":["MR\/R02118X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2019PF-2707"],"award-info":[{"award-number":["TMA2019PF-2707"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224263\/Z\/21\/Z"],"award-info":[{"award-number":["224263\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Vaccine responses are sometimes impaired in rural, low-income settings. Helminth-associated gut barrier dysfunction and microbial translocation (MT) may be implicated. We used samples from a trial of praziquantel treatment-effects on vaccine responses in\n                    <jats:italic>Schistosoma mansoni<\/jats:italic>\n                    (\n                    <jats:italic>Sm<\/jats:italic>\n                    )-endemic Ugandan islands, measuring intestinal fatty acid-binding protein 2 (I-FABP2), lipopolysaccharide-binding protein, anti-endotoxin core antibodies (EndoCab), soluble CD14 (sCD14) in plasma, and faecal lipocalin-2, occult blood (FOB), and calprotectin (fCAL), and evaluating their associations with baseline helminth infection, praziquantel treatment, and responses to BCG, yellow fever, typhoid, HPV, and tetanus-diphtheria vaccines.\n                    <jats:italic>Sm<\/jats:italic>\n                    associated positively with fCAL and FOB, hookworm with I-FABP2, and any helminth with EndoCab IgM, fCAL and FOB.\n                    <jats:italic>Sm<\/jats:italic>\n                    associated inversely with sCD14. Praziquantel treatment reduced all marker concentrations, significantly fCAL and FOB, implying that\n                    <jats:italic>Sm<\/jats:italic>\n                    -associated gut inflammation and MT is reversible. Associations of assessed markers with vaccine-specific responses were predominantly inverse. Interventions to improve gut barrier function may enhance vaccine responsiveness.\n                  <\/jats:p>","DOI":"10.1038\/s41541-025-01116-x","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:39:56Z","timestamp":1743007196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Helminth driven gut inflammation and microbial translocation associate with altered vaccine responses in rural Uganda"],"prefix":"10.1038","volume":"10","author":[{"given":"Jacent","family":"Nassuuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joas","family":"Sterk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgious","family":"Walusimbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Natukunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Nkangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Amongin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludoviko","family":"Zirimenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyaviira","family":"Nkurunungi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"1116_CR1","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1016\/j.vaccine.2014.05.042","volume":"32","author":"ML Barreto","year":"2014","unstructured":"Barreto, M. L. et al. Causes of variation in BCG vaccine efficacy: Examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses. Vaccine 32, 3759\u20133764 (2014).","journal-title":"Vaccine"},{"key":"1116_CR2","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","volume":"359","author":"GF Black","year":"2002","unstructured":"Black, G. F. et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359, 1393\u20131401 (2002).","journal-title":"Lancet"},{"key":"1116_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","volume":"346","author":"PEM Fine","year":"1995","unstructured":"Fine, P. E. M. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339\u20131345 (1995).","journal-title":"Lancet"},{"key":"1116_CR4","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1172\/JCI75429","volume":"124","author":"E Muyanja","year":"2014","unstructured":"Muyanja, E. et al. Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. J. Clin. Invest 124, 3147\u20133158 (2014).","journal-title":"J. Clin. Invest"},{"key":"1116_CR5","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1016\/j.vaccine.2016.04.080","volume":"34","author":"M Taniuchi","year":"2016","unstructured":"Taniuchi, M. et al. Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants. Vaccine 34, 3068\u20133075 (2016).","journal-title":"Vaccine"},{"key":"1116_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-014-0660-7","volume":"14","author":"R Tanner","year":"2014","unstructured":"Tanner, R. et al. Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A. BMC Infect. Dis. 14, 660 (2014).","journal-title":"BMC Infect. Dis."},{"key":"1116_CR7","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/infdis\/jiy639","volume":"219","author":"N Venkatraman","year":"2019","unstructured":"Venkatraman, N. et al. Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal. J. Infect. Dis. 219, 1187\u20131197 (2019).","journal-title":"J. Infect. Dis."},{"key":"1116_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S1473-3099(19)30126-4","volume":"19","author":"A Clark","year":"2019","unstructured":"Clark, A. et al. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. Lancet Infect. Dis. 19, 717\u2013727 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1116_CR9","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","volume":"18","author":"E Richie","year":"2000","unstructured":"Richie, E. et al. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 18, 2399\u20132410 (2000).","journal-title":"Vaccine"},{"key":"1116_CR10","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","volume":"29","author":"ML Barreto","year":"2011","unstructured":"Barreto, M. L. et al. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial. Vaccine 29, 4875\u20134877 (2011).","journal-title":"Vaccine"},{"key":"1116_CR11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1086\/522010","volume":"196","author":"E van Riet","year":"2007","unstructured":"van Riet, E. et al. Cellular and humoral responses to influenza in gabonese children living in rural and semi-urban areas. J. Infect. Dis. 196, 1671\u20131678 (2007).","journal-title":"J. Infect. Dis."},{"key":"1116_CR12","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/j.vaccine.2008.04.067","volume":"26","author":"E van Riet","year":"2008","unstructured":"van Riet, E. et al. Cellular and humoral responses to tetanus vaccination in Gabonese children. Vaccine 26, 3690\u20133695 (2008).","journal-title":"Vaccine"},{"key":"1116_CR13","doi-asserted-by":"publisher","first-page":"e1860","DOI":"10.1016\/S2214-109X(24)00340-1","volume":"12","author":"A Natukunda","year":"2024","unstructured":"Natukunda, A. et al. Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials. Lancet Glob. Health 12, e1860\u2013e1870 (2024).","journal-title":"Lancet Glob. Health"},{"key":"1116_CR14","first-page":"201","volume":"10","author":"TG Kimman","year":"2007","unstructured":"Kimman, T. G., Vandebriel, R. J. & Hoebee, B. Genetic variation in the response to vaccination. Community Genet 10, 201\u2013217 (2007).","journal-title":"Community Genet"},{"key":"1116_CR15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","volume":"70","author":"L Brandt","year":"2002","unstructured":"Brandt, L. et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70, 672\u2013678 (2002).","journal-title":"Infect. Immun."},{"key":"1116_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1189\/jlb.0606407","volume":"80","author":"DK Flaherty","year":"2006","unstructured":"Flaherty, D. K., Vesosky, B., Beamer, G. L., Stromberg, P. & Turner, J. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. J. Leukoc. Biol. 80, 1262\u20131271 (2006).","journal-title":"J. Leukoc. Biol."},{"key":"1116_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","volume":"160","author":"P Brodin","year":"2015","unstructured":"Brodin, P. et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 160, 37\u201347 (2015).","journal-title":"Cell"},{"key":"1116_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12939","volume":"44","author":"A Natukunda","year":"2022","unstructured":"Natukunda, A. et al. The effect of helminth infection on vaccine responses in humans and animal models: A systematic review and meta-analysis. Parasite Immunol. 44, e12939 (2022).","journal-title":"Parasite Immunol."},{"key":"1116_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1128\/CMR.05040-11","volume":"25","author":"HJ McSorley","year":"2012","unstructured":"McSorley, H. J. & Maizels, R. M. Helminth infections and host immune regulation. Clin. Microbiol Rev. 25, 585\u2013608 (2012).","journal-title":"Clin. Microbiol Rev."},{"key":"1116_CR20","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1084\/jem.20091473","volume":"208","author":"JA Potian","year":"2011","unstructured":"Potian, J. A. et al. Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. J. Exp. Med 208, 1863\u20131874 (2011).","journal-title":"J. Exp. Med"},{"key":"1116_CR21","doi-asserted-by":"publisher","unstructured":"Rajamanickam, A., Munisankar, S., Dolla, C., Nutman, T. B. & Babu, S. Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4)- and Programmed Death 1 (PD-1)-Mediated Regulation of Monofunctional and Dual Functional CD4(+) and CD8(+) T-Cell Responses in a Chronic Helminth Infection. Infect. Immun. 87, https:\/\/doi.org\/10.1128\/IAI.00469-19 (2019).","DOI":"10.1128\/IAI.00469-19"},{"key":"1116_CR22","doi-asserted-by":"publisher","first-page":"e1830","DOI":"10.1371\/journal.pntd.0001830","volume":"6","author":"PJ George","year":"2012","unstructured":"George, P. J. et al. Evidence of microbial translocation associated with perturbations in T cell and antigen-presenting cell homeostasis in hookworm infections. PLoS Negl. Trop. Dis. 6, e1830 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1116_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4269\/ajtmh.2011.10-0397","volume":"84","author":"D Onguru","year":"2011","unstructured":"Onguru, D. et al. Short Report: Human Schistosomiasis Is Associated with Endotoxemia and Toll-Like Receptor 2-and 4-Bearing B Cells. Am. J. Tropical Med. Hyg. 84, 321\u2013324 (2011).","journal-title":"Am. J. Tropical Med. Hyg."},{"key":"1116_CR24","doi-asserted-by":"publisher","unstructured":"Rajamanickam, A. et al. Microbial Translocation Associated with an Acute-Phase Response and Elevations in MMP-1, HO-1, and Proinflammatory Cytokines in Strongyloides stercoralis Infection. Infect. Immun. 85, https:\/\/doi.org\/10.1128\/iai.00772-16 (2017).","DOI":"10.1128\/iai.00772-16"},{"key":"1116_CR25","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jaci.2017.01.016","volume":"140","author":"AJ McFarlane","year":"2017","unstructured":"McFarlane, A. J. et al. Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota. J. Allergy Clin. Immunol. 140, 1068\u20131078.e1066 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1116_CR26","doi-asserted-by":"publisher","first-page":"e1826","DOI":"10.1016\/S2214-109X(24)00280-8","volume":"12","author":"G Nkurunungi","year":"2024","unstructured":"Nkurunungi, G. et al. The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial. Lancet Glob. Health 12, e1826\u2013e1837 (2024).","journal-title":"Lancet Glob. Health"},{"key":"1116_CR27","doi-asserted-by":"publisher","unstructured":"Natukunda, A. et al. Pre-vaccination Schistosoma mansoni and hookworm infections are associated with altered vaccine immune responses: a longitudinal analysis among adolescents living in helminth-endemic islands of Lake Victoria, Uganda. Front. Immunol. 15, https:\/\/doi.org\/10.3389\/fimmu.2024.1460183 (2024).","DOI":"10.3389\/fimmu.2024.1460183"},{"key":"1116_CR28","doi-asserted-by":"publisher","first-page":"e2542","DOI":"10.1371\/journal.pntd.0002542","volume":"7","author":"AL Bustinduy","year":"2013","unstructured":"Bustinduy, A. L. et al. Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection. PLOS Neglected Tropical Dis. 7, e2542 (2013).","journal-title":"PLOS Neglected Tropical Dis."},{"key":"1116_CR29","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.3389\/fimmu.2018.02492","volume":"9","author":"C Schwartz","year":"2018","unstructured":"Schwartz, C. & Fallon, P. G. Schistosoma \u201cEggs-Iting\u201d the Host: Granuloma Formation and Egg Excretion. Front Immunol. 9, 2492 (2018).","journal-title":"Front Immunol."},{"key":"1116_CR30","doi-asserted-by":"publisher","unstructured":"Walusimbi, B. et al. The effects of helminth infections on the human gut microbiome: a systematic review and meta-analysis. Front. Microbiomes 2, https:\/\/doi.org\/10.3389\/frmbi.2023.1174034 (2023).","DOI":"10.3389\/frmbi.2023.1174034"},{"key":"1116_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/gutjnl-2021-325428","volume":"71","author":"M Camilleri","year":"2022","unstructured":"Camilleri, M. & Vella, A. What to do about the leaky gut. Gut 71, 424\u2013435 (2022).","journal-title":"Gut"},{"key":"1116_CR32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2217\/fmb-2018-0016","volume":"13","author":"JA Church","year":"2018","unstructured":"Church, J. A. et al. Exploring the Relationship Between Environmental Enteric Dysfunction and Oral Vaccine Responses. Future Microbiol. 13, 1055\u20131070 (2018).","journal-title":"Future Microbiol."},{"key":"1116_CR33","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.ebiom.2015.09.036","volume":"2","author":"C Naylor","year":"2015","unstructured":"Naylor, C. et al. Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh. EBioMedicine 2, 1759\u20131766 (2015).","journal-title":"EBioMedicine"},{"key":"1116_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.it.2014.07.003","volume":"35","author":"Y Valdez","year":"2014","unstructured":"Valdez, Y., Brown, E. M. & Finlay, B. B. Influence of the microbiota on vaccine effectiveness. Trends Immunol. 35, 526\u2013537 (2014).","journal-title":"Trends Immunol."},{"key":"1116_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41577-023-00941-2","volume":"24","author":"M van Dorst","year":"2024","unstructured":"van Dorst, M. et al. Immunological factors linked to geographical variation in vaccine responses. Nat. Rev. Immunol. 24, 250\u2013263 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1116_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/MCG.0b013e31829e4632","volume":"48","author":"B Raone","year":"2014","unstructured":"Raone, B., Raboni, R. & Patrizi, A. Probiotics Reduce Gut Microbial Translocation and Improve Adult Atopic Dermatitis. J. Clin. Gastroenterol. 48, 95\u201396 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"1116_CR37","doi-asserted-by":"publisher","first-page":"e040426","DOI":"10.1136\/bmjopen-2020-040426","volume":"11","author":"G Nkurunungi","year":"2021","unstructured":"Nkurunungi, G. et al. Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the \u2018POPulation differences in VACcine responses\u2019 (POPVAC) programme. BMJ Open 11, e040426 (2021).","journal-title":"BMJ Open"},{"key":"1116_CR38","first-page":"ciy761","volume":"68","author":"RE Sanya","year":"2018","unstructured":"Sanya, R. E. et al. The Impact of Intensive Versus Standard Anthelminthic Treatment on Allergy-related Outcomes, Helminth Infection Intensity, and Helminth-related Morbidity in Lake Victoria Fishing Communities, Uganda: Results From the LaVIISWA Cluster-randomized Trial. Clin. Infect. Dis. 68, ciy761\u2013ciy761 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"1116_CR39","unstructured":"Beaty, B. J. et al. 204-205 (American Public Health Association, 1995)."},{"key":"1116_CR40","doi-asserted-by":"publisher","first-page":"e0008783","DOI":"10.1371\/journal.pntd.0008783","volume":"14","author":"MM Gibani","year":"2020","unstructured":"Gibani, M. M. et al. Homologous and heterologous re-challenge with Salmonella typhi and Salmonella paratyphi A in a randomised controlled human infection model. PLoS Negl. Trop. Dis. 14, e0008783 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1116_CR41","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1016\/j.vaccine.2010.06.018","volume":"28","author":"JG Dauner","year":"2010","unstructured":"Dauner, J. G., Pan, Y., Hildesheim, A., Harro, C. & Pinto, L. A. Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine. Vaccine 28, 5407\u20135413 (2010).","journal-title":"Vaccine"},{"key":"1116_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mcp.2012.01.002","volume":"26","author":"JG Dauner","year":"2012","unstructured":"Dauner, J. G. et al. Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals. Mol. Cell Probes 26, 73\u201380 (2012).","journal-title":"Mol. Cell Probes"},{"key":"1116_CR43","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1016\/j.vaccine.2021.07.069","volume":"39","author":"CN Miller","year":"2021","unstructured":"Miller, C. N. et al. Increases in HPV-16\/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine. Vaccine 39, 5295\u20135301 (2021).","journal-title":"Vaccine"},{"key":"1116_CR44","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/infdis\/jiw359","volume":"214","author":"LA Pinto","year":"2016","unstructured":"Pinto, L. A. et al. Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial. J. Infect. Dis. 214, 1276\u20131283 (2016).","journal-title":"J. Infect. Dis."},{"key":"1116_CR45","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1017\/S0031182014000626","volume":"141","author":"PL Corstjens","year":"2014","unstructured":"Corstjens, P. L. et al. Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels. Parasitology 141, 1841\u20131855 (2014).","journal-title":"Parasitology"},{"key":"1116_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1049\/ip-nbt:20045014","volume":"152","author":"PL Corstjens","year":"2005","unstructured":"Corstjens, P. L. et al. Infrared up-converting phosphors for bioassays. IEE Proc. Nanobiotechnol 152, 64\u201372 (2005).","journal-title":"IEE Proc. Nanobiotechnol"},{"key":"1116_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1128\/JCM.00877-07","volume":"46","author":"PL Corstjens","year":"2008","unstructured":"Corstjens, P. L. et al. Up-converting phosphor technology-based lateral flow assay for detection of Schistosoma circulating anodic antigen in serum. J. Clin. Microbiol 46, 171\u2013176 (2008).","journal-title":"J. Clin. Microbiol"},{"key":"1116_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-017-0368-1","volume":"6","author":"P Corstjens","year":"2017","unstructured":"Corstjens, P., Hoekstra, P. T., de Dood, C. J. & van Dam, G. J. Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies. Infect. Dis. Poverty 6, 155 (2017).","journal-title":"Infect. Dis. Poverty"},{"key":"1116_CR49","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4269\/ajtmh.2007.77.685","volume":"77","author":"JJ Verweij","year":"2007","unstructured":"Verweij, J. J. et al. Simultaneous detection and quantification of Ancylostoma duodenale, Necator americanus, and Oesophagostomum bifurcum in fecal samples using multiplex real-time PCR. Am. J. Trop. Med Hyg. 77, 685\u2013690 (2007).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"1116_CR50","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.trstmh.2008.12.001","volume":"103","author":"JJ Verweij","year":"2009","unstructured":"Verweij, J. J. et al. Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans. R. Soc. Trop. Med Hyg. 103, 342\u2013346 (2009).","journal-title":"Trans. R. Soc. Trop. Med Hyg."},{"key":"1116_CR51","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0009-9120(03)00096-1","volume":"36","author":"MM Pelsers","year":"2003","unstructured":"Pelsers, M. M. et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin. Biochem 36, 529\u2013535 (2003).","journal-title":"Clin. Biochem"},{"key":"1116_CR52","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/apt.12194","volume":"37","author":"MP Adriaanse","year":"2013","unstructured":"Adriaanse, M. P. et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharm. Ther. 37, 482\u2013490 (2013).","journal-title":"Aliment Pharm. Ther."},{"key":"1116_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MCG.0b013e3182a87e3e","volume":"48","author":"DH Schellekens","year":"2014","unstructured":"Schellekens, D. H. et al. Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model. J. Clin. Gastroenterol. 48, 253\u2013260 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"1116_CR54","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/QAD.0000000000001771","volume":"32","author":"M Epeldegui","year":"2018","unstructured":"Epeldegui, M. et al. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma. Aids 32, 945\u2013954 (2018).","journal-title":"Aids"},{"key":"1116_CR55","doi-asserted-by":"publisher","first-page":"e134092","DOI":"10.1172\/jci.insight.134092","volume":"5","author":"A Shieh","year":"2020","unstructured":"Shieh, A., Epeldegui, M., Karlamangla, A. S. & Greendale, G. A. Gut permeability, inflammation, and bone density across the menopause transition. JCI Insight 5, e134092 (2020).","journal-title":"JCI Insight"},{"key":"1116_CR56","doi-asserted-by":"publisher","first-page":"e44328","DOI":"10.1371\/journal.pone.0044328","volume":"7","author":"B Chassaing","year":"2012","unstructured":"Chassaing, B. et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One 7, e44328 (2012).","journal-title":"PLoS One"},{"key":"1116_CR57","doi-asserted-by":"publisher","first-page":"65386","DOI":"10.18632\/oncotarget.18528","volume":"8","author":"BX Guo","year":"2017","unstructured":"Guo, B. X. et al. Lipocalin 2 regulates intestine bacterial survival by interplaying with siderophore in a weaned piglet model of Escherichia coli infection. Oncotarget 8, 65386\u201365396 (2017).","journal-title":"Oncotarget"},{"key":"1116_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1015372","volume":"13","author":"SK Yadav","year":"2022","unstructured":"Yadav, S. K. et al. Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis. Front Immunol. 13, 1015372 (2022).","journal-title":"Front Immunol."},{"key":"1116_CR59","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","volume":"12","author":"MR Konikoff","year":"2006","unstructured":"Konikoff, M. R. & Denson, L. A. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm. Bowel Dis. 12, 524\u2013534 (2006).","journal-title":"Inflamm. Bowel Dis."},{"key":"1116_CR60","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin, S. A. Correlates of protection induced by vaccination. Clin. Vaccin. Immunol. : CVI 17, 1055\u20131065 (2010).","journal-title":"Clin. Vaccin. Immunol. : CVI"},{"key":"1116_CR61","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1086\/513984","volume":"175","author":"H Kollaritsch","year":"1997","unstructured":"Kollaritsch, H. et al. Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine. J. Infect. Dis. 175, 871\u2013875 (1997).","journal-title":"J. Infect. Dis."},{"key":"1116_CR62","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1056\/NEJMoa1710430","volume":"381","author":"RM Casey","year":"2019","unstructured":"Casey, R. M. et al. Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report. N. Engl. J. Med 381, 444\u2013454 (2019).","journal-title":"N. Engl. J. Med"},{"key":"1116_CR63","doi-asserted-by":"publisher","first-page":"e89212","DOI":"10.1371\/journal.pone.0089212","volume":"9","author":"Y Jiang","year":"2014","unstructured":"Jiang, Y. et al. MCPerm: a Monte Carlo permutation method for accurately correcting the multiple testing in a meta-analysis of genetic association studies. PLoS One 9, e89212 (2014).","journal-title":"PLoS One"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01116-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01116-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01116-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T05:25:06Z","timestamp":1743312306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01116-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01116-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5201954\/v1","asserted-by":"object"}]},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.N. and A.M.E. report grants from Wellcome Trust. G.N. reports funding from the EDCTP2 programme supported by the European Union. A.M.E. reports funding from Medical Research Council (MRC) of the United Kingdom for conduct of the parent study; A.M.E. reports funding from NIH, Science for Africa Foundation, the Royal Society, and DELTAS Africa, outside the submitted work. A.M.E. and A.N. report support from UK National Institute of Health and care Research (NIHR). A.M.E. further reports support from the Serum Institute of India, Uganda National Expanded Programme on Immunisation, and Emergent BioSolutions for conduct of the parent study. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}